Next Article in Journal
Advanced Strategies of Drug Delivery via Oral, Topical, and Parenteral Administration Routes: Where Do Equine Medications Stand?
Next Article in Special Issue
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn’s Disease but Not Ulcerative Colitis Patients
Previous Article in Journal
Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care
Previous Article in Special Issue
Airway Epithelial Cell Junctions as Targets for Pathogens and Antimicrobial Therapy
 
 
Article

Article Versions Notes

Pharmaceutics 2023, 15(1), 185; https://doi.org/10.3390/pharmaceutics15010185
Action Date Notes Link
article xml file uploaded 4 January 2023 12:06 CET Original file -
article xml uploaded. 4 January 2023 12:06 CET Update -
article pdf uploaded. 4 January 2023 12:06 CET Version of Record -
article html file updated 4 January 2023 12:08 CET Original file -
article xml file uploaded 4 January 2023 14:05 CET Update -
article xml uploaded. 4 January 2023 14:05 CET Update https://www.mdpi.com/1999-4923/15/1/185/xml
article pdf uploaded. 4 January 2023 14:05 CET Updated version of record https://www.mdpi.com/1999-4923/15/1/185/pdf
article html file updated 4 January 2023 14:06 CET Update -
article html file updated 1 March 2023 07:46 CET Update -
article html file updated 7 March 2023 20:24 CET Update https://www.mdpi.com/1999-4923/15/1/185/html
Back to TopTop